Mumbai, Pharma major Indoco Remedies said that it has received approval for its ANDA for Apixaban Tablets 2.5mg & 5mg from US Food and Drug Administration (USFDA).The products are therapeutically equivalent to the Reference Listed Drug ‘Eliquis’ of Bristol-Myers Squibb (BMS).Apixaban is an anticoagulant, or blood thinner. It is used for patients with health problems caused by a blood clot.
The US market size of Apixaban Tablets is USD 11,037 million as per IMS MAT June’20 data.
Commenting on this development, Ms Aditi Kare Panandikar, Managing Director – Indoco Remedies Ltd said, “The receipt of approval from the US health regulator for the generic version of Apixaban Tablets is encouraging.”